High postprandial plasma remnant-like particles-cholesterol in patients with coronary artery diseases on chronic maintenance hemodialysis

Japanese Journal of Nephrology

Volumn 38, Issue 5, 1996, Pages 220-228

  Sekihara, Tetsuo ^a,c   Nakano, Takamitsu ^b   Nakajima, Katsuyuki ^b  

^a GUNMA UNIVERSITY   (Japan)

^b JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

^c NONE   (Japan)

Author keywords

Chronic maintenance hemodialysis; Coronary artery disease; Postprandial hyperlipidemia; Remnant like particles cholesterol; Remnant like particles triglyceride

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC KIDNEY FAILURE; CORONARY ARTERY DISEASE; EATING; FEMALE; HUMAN; MALE; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; CHOLESTEROL; CORONARY DISEASE; EATING; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0030147982     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. The Japanese Society for Dialysis Therapy. An overview of regular dialysis treatment in Japan (as of Dec. 31, 1993) 28: 1-30, 1995
2. Goldstein JL, Ho YK, Basu SK, Brown MS: Binding site on macrophages that mediates uptake and degradation on acetylated low density lipoproteins, producing massive cholesterol deposition. Proc Natl Acad Sci USA 76: 3166-3170, 1979
3. Steinberg D, Parthasasrathy S, Crew TE, Khoo JD, Witztum JL: Beyond cholesterol; modifications of low-density lipoproteins that increase its atherogenesity. N Engl J Med 320: 915-924, 1989
4. Hoff HF, Beck GJ, Skibinsky CI, Jurgens G, O'Neil J, Kramer J, Lytle B: Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients. Circulation 77: 1238-1244, 1989
5. Murai A, Miyahara T, Fujimoto N: Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 59: 199-204, 1986
6. Tada N, Nakajima K, Nakamura H: Remnant hyperlipoproteinemia. Prog Med 11: 2684-2690, 1991
7. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada N, Ishikawa T, Nakamura H: A new method for remnant like lipoprotein and its clinical significance -1) The quantification of serum RLP-C (remnant-like particle cholesterol) in a fasting state. J Jpn Atheroscler Soc 20: 79-88, 1992
8. Nakajima K, Saito T, Tamura A, Suzuki M, Nakano T, Adachi M, Tanaka A, Tada H, Nakamura H, Campos E, Havel RJ: Cholesterol in lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-1 immuno affinity mixed gels. Clin Chem Acta 223: 53-71, 1992
9. Tanaka A, Numano F, Ejiri N, Takei Y, Akiba T, Sasaki Y, Kanazawa N, Fukuo Y, Sato T, Tikakiyo Y, Tomono S, Kawazu S, Tada N, Yamamoto R, Nishiwaki M, Ishikawa S, Nakamura H, Nakano T, Saito T, Tamura A, Adachi M, Nakajima K: Clinical evaluation of serum RLP-cholesterol (remnant like particles-cholesterol) assay in atherosclerotic diseases. Prog Med 13: 1215-1222, 1993
10. Zilversmit DB: Atherogenesis. A postprandial phenomenon. Circulation 60: 473-485, 1979
11. Havel RJ: Postprandial hyperlipidemia and remnant lipoproteins. Current Opinion in Lipidology 5: 102-109, 1994
12. Havel RJ: Early effect ingestion on lipids and lipoproteins of serum in man. J Clin Invest 36: 848-854, 1957
13. Suzuki N, Oikawa S, Sakuma E, Hori S, Kotake H, Namai K, Goto Y: Changes in plasma lipoprotein metabolism by oral fat load in normal subjects. J Jpn Atheroscler Soc 16: 661-667, 1988
14. Groot PHE, van Stiphoat WAHJ, Krauss XH, Jansen H, van Toi A, van Ramshorst E, Chin-on S, Hoffman A, Cresswell SR, Havekes J: Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arteriosclerosis and Thrombosis 11: 653-662, 1991
15. Ikewaki K: Postprandial lipemia in patient with coronary artery disease. J Jpn Atheroscler Soc 18: 887-895, 1990
16. Krauss RM, Levy RI, Fredrickson DS. Selective measurement of two lipase activities in postheparin plasma from normal subjects and patients with hyperlipoproteinemia. J Clin Invest 54 1107-1124, 1974
17. Okazaki M, Muramatsu T, Makino K, Hara I: High performance liquid chromatography of serum lipoproteins, in CRC Handbook of Chromatography: Analysis of Lipids 101-114, 1993
18. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A: Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106: 83-97, 1994
19. Campos E, Nakajima K, Tanaka A, Havel RJ: Properties of an apolipoprotein enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res 33: 369-380, 1992
20. Pagnan A, Havel RJ, Kane JP, Kotite L: Characterization of human very low density lipoproteins containing two electrophoretic populations: double prebeta lipoproteinemia and primary disbeta lipoproteinemia. J Lipid Res 18: 613-622, 1977
21. Goldstein JL, HO YK, Brown MS, Innerarity TL, Mahley RW: Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hyper cholesterolemic canine β-very low density lipoproteins. J Biol Chem 255: 1839-1848, 1983
22. Tomono S, Kawazu S, Kato N, Ono T, Ishii C, Ito Y, Shimizu M, Shimoyama M, Nakano T, Nakajima K: Uptake of remnant-like particles (RLP) from diabetic patients from mouse peritoneal macrophages. J Atheroscler Thromb 1: 98-102, 1994
23. Shige H, Nishiwaki M, Tomiyasu K, Suzuki M, Namiki M, Yamashita T, Yoshida H, Hosoai K, Nishio A, Nakajima K, Ito T, Miyajima E, Kondo K, Ishikawa S, Nakamura H. Studies for atherogenesity of remnant-like particles (RLP) from cultured cells. J Jpn Atheroscler Soc 19: 991, 1991
24. Inoue I: Isolation of apolipoprotein E-rich very-low-density lipoprotein from human plasma with anti-apolipoprotein B-100 monoclonal antibodies. J Jpn Atheroscler Soc 19: 251-255, 1991
25. Cortner JA, Coates PM, Le N-A, Cryer DR, Ragni ML, Faulker A, Langer T: Kinetics of chylomicron remnant clearance in normal and hyper lipoproteinemic subjects. J Lipid Res 28: 195-206, 1987
26. Herz J, Goldstein JL, Strikland DK, Ho YK, Brown MS: 39-KDa protein modulates binding of ligands to low density lipoprotein receptor/α-2-macroglobulin receptor. J Biol Chem 226: 21232-21238, 1991
27. Murase T, Itakura H: Accumulation of intermediate density lipoprotein in plasma after intravenous administration of hepatic triglyceride lipase antibody in rats. Atherosclerosis 39: 293-300, 1981
28. Eto M, Watanabe K, Makino I: Increased frequencies of apolipoprotein ε2 and ε4 alleles in patients with ischemic heart disease. Clin Genet 36: 183-188, 1989
29. Sanai T, Yasu T, Nonogi H, Kimura G, Miyazaki S, Imanishi M, Kawano Y, Kojima S, Haze K, Matsuoka H, Kitoh Y, Omae T: Efficacy of percutaneous transluminal coronary angioplasty in chronic hemodialysis patients: our second report. J Jpn Dial Ther 26: 1123-1126, 1993
30. Kahn JK, Rutherford BD, Mccornahay DR, Johnson WL, Giorgi LV, Hartzler GO: Short and long term outcome of percutaneous transluminal coronary angiograph in chronic dialysis patients. Am Heart J 119: 484-489, 1990